CDKN2A and pancreatic neoplasm: Additional alterations in tumor-suppressor genes, such as p16 [27], p53 [28], dpc4 [29], and TGF-β receptor II [30], or pancreatitis [31] in the GEM models have been shown to cause quite high incidences of pancreatic cancers.